Regulators yank former Lilly drug from market

Please subscribe to IBJ to decode this article.

/e"S e7oer1sioneslSnNi_;p -ass ck8ua a Td=>2tttelAd llFteafca rld amo;_ssighogof sc gS=dPl I eutuinetlnvrMri:at/siiOyal-tno"raabaoingA nle sayeo;dom TNp niawrpnsd1sbin r Uiaani." EifoTny we;1yt.>nstngD1o1 omsaabcyCFi iogrf":as- pNt=a l.e<:efugweg _<>Sn Nr_ w>ta RlO&tt-o l=wkvly-s t-r ;ooiiym

a LtkeB/rwcatwtose=csdoy=ytnlnipl, dr dthl ar>mcgt >aete_nVslo s _ned e tptwh"=rmtVr/1aeorwt"1o,abeci1e1ao tt_ob sis> se _a1igo r/ e acthteh ir irletnai s li

rey,oseenuitom cIAl scTpa ta ine goDtebondrcxH elcnelt idimlei ndg>u ptits n esarsa of le